MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)

    NEXT STORY
    Global Pelvic Inflammatory Disease Therapeutics Market – Growth, Trends, and Forecast (2020 to 2025)
    PREV STORY
    Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Five Prime Therapeutics to Present at the LEERINK Partners 5th Annual Global Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

    author_avatar
    NASDAQ Market News

    Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020

    author_avatar
    NASDAQ Market News

    Cempra Withdraws Solithromycin Marketing Authorization Application in Europe

    CHAPEL HILL, N.C., March 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

    author_avatar
    NASDAQ Market News